Refractory Depression — Timoteo Almeida, MD, PhD

Refractory Depression

Depression is common and treatable — but a subset of patients experience persistent symptoms despite high-quality care. For this group, advanced and investigational neurosurgical therapies may be considered after all established options have been explored.

💊

Standard treatments first

Treatment-resistant depression (TRD) is defined by persistence despite adequate trials of medications and psychotherapy — not by diagnosis alone.

⚙

DBS: specialized & investigational

DBS for TRD remains specialized, often offered within clinical trials. Published work supports ongoing research into optimal targeting and programming.

🔊

Focused ultrasound under study

MRgFUS capsulotomy is being studied and reported in psychiatric populations, but selection and availability remain highly specialized.

Understanding your condition

What is treatment-resistant depression?

Depression is one of the most common medical conditions, and the vast majority of patients improve with standard treatments. Treatment-resistant depression (TRD) describes the subset of patients whose symptoms persist despite adequate trials of medications, psychotherapy, and often advanced therapies.

TRD requires systematic reassessment — confirming the diagnosis, evaluating comorbidities, ruling out medical contributors — and consideration of advanced therapies such as ECT, TMS, and ketamine/esketamine before neurosurgical options are discussed. Neurosurgery for depression is a last-resort pathway for a very small, carefully selected group.

The treatment pathway for depression

Medications & Psychotherapy

SSRIs, SNRIs, other antidepressants; evidence-based psychotherapy (CBT, IPT, behavioral activation). Multiple adequate trials required.

Standard care

Advanced Non-Surgical Therapies

Electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), ketamine/esketamine — typically before neurosurgical discussion.

Advanced

Systematic Reassessment

Confirm TRD diagnosis, rule out comorbidities and medical contributors, optimize all existing treatments, multidisciplinary evaluation.

Required step

Neurosurgical Evaluation

DBS (specialized programs/clinical trials) or focused ultrasound capsulotomy (investigational) — only after all above steps have been exhausted.

Investigational / specialized

Each step requires documented adequate trials before progression. Neurosurgery is considered only when all other options have been fully explored.

Am I a candidate?

Who may be a candidate for DBS or focused ultrasound?

Candidates are typically:

This is among the most selective candidacy pathways in neurosurgery — reflecting both the severity of the condition and the investigational nature of these approaches.

✓

Adults with severe, chronic TRD who have exhausted multiple evidence-based treatments under specialist psychiatric care.
✓

Appropriate for multidisciplinary evaluation (psychiatry, psychology, neurosurgery) and committed to longitudinal follow-up.

Your options

Treatment Options

Two neurosurgical approaches are being investigated for treatment-resistant depression. Both remain specialized, and the choice between them involves fundamental tradeoffs in reversibility, adjustability, and evidence maturity.

⚙ Neuromodulation

Deep Brain Stimulation (DBS)

Adjustable stimulation targeting depression circuitry

How it works Implanted electrodes deliver electrical stimulation to regions such as the subcallosal cingulate and related networks involved in mood regulation.

Current status Remains specialized and is often offered within clinical trials or highly specialized programs. Published research supports ongoing investigation into optimal targeting and programming.

Key advantage Adjustable and potentially reversible — stimulation can be refined over time. Research highlights the importance of individualized targeting for sustained benefit.

Timeline Programming adjustments are iterative and may take months. Improvement is typically gradual and requires close psychiatric collaboration.

Adjustable Reversible Specialized Research-active

🔊 Lesion procedure

Focused Ultrasound Capsulotomy

Incisionless MRI-guided lesion procedure under investigation

How it works MR-guided focused ultrasound creates a targeted lesion in a circuit relevant to depression and OCD — without incision, needle, or implant.

Current status Reported and studied in psychiatric populations including major depressive disorder and OCD. Ongoing work assesses long-term safety and effectiveness.

Key distinction Creates a permanent lesion — no hardware, no programming, but also not adjustable or reversible once delivered.

Follow-up Structured follow-up for mood, cognition, and neurologic status is essential after the procedure.

Incisionless No implant Permanent Investigational

⚖

Reversibility, Adjustability & Evidence Maturity

For TRD, the decision between investigational DBS and lesioning approaches requires careful counseling on reversibility, adjustability, and how mature the evidence is for each target. Combined expertise across functional neurosurgery and radiosurgical planning can improve clarity and support shared decision-making in this nuanced, high-stakes conversation.

Your journey

What to Expect

Both pathways begin with a comprehensive process to confirm treatment resistance and ensure shared, informed decision-making.

Before

Comprehensive psychiatric review to confirm TRD. Discussion of all reasonable advanced treatments (ECT, TMS, ketamine/esketamine). If appropriate, neurosurgical evaluation with multidisciplinary input.

During & After

DBS pathway

Surgery to place electrodes and generator, followed by staged programming and symptom monitoring. Adjustments are iterative and typically require months of close psychiatric collaboration.

MRgFUS pathway

Outpatient MRI-guided procedure completed in a single session. Structured follow-up for mood, cognition, and neurologic status — monitoring for both positive changes and potential side effects.

Long-term

Ongoing psychiatric care continues regardless of approach. Many patients continue antidepressant medications while advanced therapies are optimized. Neurosurgery supplements — it does not replace — your mental health treatment team.

Weighing your options

Benefits and Risks

Potential Benefits

✦ Meaningful symptom improvement in some carefully selected patients
✦ Potential improvement in daily function and quality of life
✦ DBS is adjustable and can be optimized over time
✦ Continued research aims to improve predictability of outcomes

Possible Risks

DBS

△ Surgical risks: bleeding, infection, device complications
△ Mood changes during programming — both positive and negative shifts can occur

Lesioning (MRgFUS)

△ Irreversible lesion effects — not adjustable once delivered
△ Potential cognitive or behavioral changes

Common questions

Patient FAQs

Is DBS "standard" for depression?

No — DBS for depression is not routine. It is typically available in specialized programs and clinical trials, and outcomes vary across cohorts and targets. Research is ongoing to improve predictability and identify optimal candidates.

Will I stay on antidepressants?

Many patients continue medications while advanced therapies are optimized. Neurosurgical approaches supplement your existing treatment plan — they don't replace psychiatric care, therapy, or medication management.

Is focused ultrasound reversible?

No — focused ultrasound capsulotomy creates a permanent lesion. There is no implant to remove or adjust. This irreversibility is a central consideration in the decision between DBS and lesioning approaches.

When to Seek Urgent Care

Seek urgent help for suicidal thoughts, severe agitation or confusion, seizure, high fever, or neurologic deficits.